CIBC Asset Management Inc Lowers Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

CIBC Asset Management Inc cut its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 7.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,874 shares of the company’s stock after selling 248 shares during the quarter. CIBC Asset Management Inc’s holdings in Prestige Consumer Healthcare were worth $224,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Sanctuary Advisors LLC grew its holdings in shares of Prestige Consumer Healthcare by 5.4% during the fourth quarter. Sanctuary Advisors LLC now owns 18,175 shares of the company’s stock worth $1,425,000 after buying an additional 927 shares in the last quarter. Principal Financial Group Inc. grew its holdings in Prestige Consumer Healthcare by 3.2% in the fourth quarter. Principal Financial Group Inc. now owns 256,526 shares of the company’s stock valued at $20,032,000 after purchasing an additional 7,890 shares during the period. Congress Asset Management Co. grew its holdings in Prestige Consumer Healthcare by 5.0% in the fourth quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock valued at $70,964,000 after purchasing an additional 43,619 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in Prestige Consumer Healthcare by 3.1% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock valued at $126,274,000 after purchasing an additional 49,331 shares during the period. Finally, Meritage Portfolio Management grew its holdings in Prestige Consumer Healthcare by 7.0% in the fourth quarter. Meritage Portfolio Management now owns 12,826 shares of the company’s stock valued at $1,002,000 after purchasing an additional 834 shares during the period. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Up 2.8 %

Shares of NYSE:PBH opened at $87.46 on Wednesday. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The company has a fifty day simple moving average of $79.53 and a 200 day simple moving average of $76.75. The firm has a market cap of $4.33 billion, a PE ratio of 20.48, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $88.36.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PBH has been the subject of a number of recent analyst reports. Sidoti downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a report on Monday, December 9th. Oppenheimer lifted their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. DA Davidson lifted their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Finally, Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $92.60.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.